Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Airgraft was a medical technology company that developed a precision vaporization platform for the delivery of cannabis extracts. The company's technology focused on thermal efficiency and dose control, utilizing a unique Secure Pod system to prevent tampering and ensure oil integrity. Airgraft's platform was designed to eliminate harmful byproducts of combustion and overheating, providing a cleaner inhalation experience for patients and consumers. Their business model integrated high-end hardware with a software-locked ecosystem to ensure only verified, high-quality oils were used. Despite its innovative approach to clean vapor and dose management, the company reportedly ceased its primary operations in late 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Airgraft.